Thus, the effects of these studies on atherosclerosis are likely to be compounded by toxic effects of higher dose LPS unrelated to TLR4 and may not be truly reflective of low-grade inflammation induced by pathologically relevant dosages of endotoxemia. This evidence concerns the gene TLR4 and atherosclerosis.